| Nov 13 |
Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference
|
| Nov 12 |
Supernus Pharmaceuticals: Recently Launched Qelbree Is Powering Growth
|
| Nov 6 |
Supernus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 5 |
Supernus Pharmaceuticals Inc (SUPN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
| Nov 5 |
Supernus Pharmaceuticals, Inc. (SUPN) Q3 2024 Earnings Call Transcript
|
| Nov 5 |
Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to Say
|
| Nov 5 |
Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates
|
| Nov 4 |
Supernus: Q3 Earnings Snapshot
|
| Nov 4 |
Supernus Pharmaceuticals GAAP EPS of $0.69, revenue of $175.69M beats by $18.39M
|
| Nov 4 |
Supernus Announces Third Quarter 2024 Financial Results
|
